KOPN.NASDAQKopin CORP

S-1/A: Kopin Corp. Files for Resale of 19.5M Shares

Sentiment:

Amendment to Registration Statement for Resale of Securities


Kopin Corporation filed an S-1/A registration statement for the resale of up to 19,545,950 shares of common stock by existing selling stockholders, with no proceeds going to the company.

Capital raiseOn September 29, 2025, the company completed a private investment in public equity (PIPE) financing for 19,545,950 shares of common stock at $2.10 per share, generating approximately $38.1 million in net proceeds for the company.On October 16, 2025, Theon International Plc completed a $15.0 million strategic investment, which included an $8.0 million equity investment in Kopin Europe Limited and a $7.0 million purchase of Series A Convertible Preferred Stock.The company explicitly states it may need to raise additional capital to fund operations to continue as a going concern.
Worse than expectedThe company has a history of significant net operating losses and an accumulated deficit of $402.0 million as of December 28, 2024.It has experienced negative cash flow from operating activities in fiscal years 2022, 2023, and 2024, and expects this trend to continue in fiscal year 2025.Management has concluded that there is substantial doubt about the company's ability to continue as a going concern within one year.Material weaknesses in internal controls over financial reporting were identified as of December 28, 2024.A post-trial order awarded $19.7 million in damages against the company in a legal proceeding.

Summary

  • The filing registers up to 19,545,950 shares of common stock for resale by identified selling stockholders.
  • The shares were originally issued in a private placement (PIPE) on September 29, 2025, at a purchase price of $2.10 per share.
  • Kopin Corporation will not receive any proceeds from the sale of these shares by the selling stockholders; the company will bear all registration expenses.
  • Recent developments include a $15.4 million Other Transaction Agreement (OTA) award for MicroLED display development for defense applications.
  • The company was awarded an approximate $9 million follow-on production contract for a custom thermal imaging assembly for a major U.S. defense prime contractor.
  • A post-trial order on September 5, 2025, awarded BlueRadios, Inc. approximately $19.7 million in damages against Kopin, which the company is appealing with a $23.0 million bond.
  • A $15.0 million strategic investment from Theon International Plc closed on October 16, 2025, including an $8.0 million equity investment in Kopin Europe Limited (49% interest) and a $7.0 million purchase of Series A Convertible Preferred Stock.
  • The Series A Convertible Preferred Stock is convertible into common stock at an initial fixed conversion price of $3.00 per share, with a mandatory conversion at $5.50, and carries a 4% annual dividend (2% cash, 2% stock).
  • The company has a history of losses, a significant accumulated deficit of $402.0 million as of December 28, 2024, and negative cash flow from operating activities in fiscal years 2022, 2023, and 2024, with expectations for negative cash flow in 2025.
  • Management identified material weaknesses in internal controls over financial reporting as of December 28, 2024, and has expressed substantial doubt about the company's ability to continue as a going concern within one year.

Sentiment

Score: 3

Explanation: The company faces severe financial challenges, including a history of losses, persistent negative operating cash flow, and a 'going concern' warning. Material weaknesses in internal controls and a significant legal judgment further compound these issues. While recent strategic investments and defense contracts offer some positive momentum, the fundamental financial health and operational risks are substantial.

Positives

  • Secured a transformative $15.4 million Other Transaction Agreement (OTA) from the Office of the Secretary of Defense (OSD) for ultra-bright, full-color MicroLED displays optimized for ground soldier augmented reality (AR) applications, positioning the company as a cornerstone of America's defense innovation and domestic manufacturing ecosystem.
  • Awarded an approximate $9 million follow-on production contract in support of a custom thermal imaging assembly build for a major U.S. defense prime contractor.
  • Completed a $15.0 million strategic investment by Theon International Plc, which includes an $8.0 million investment in Kopin Europe Limited for a 49% equity interest and a $7.0 million purchase of Series A Convertible Preferred Stock, supporting co-developed products for Europe, Southeast Asia, and NATO countries.
  • The original PIPE financing on September 29, 2025, generated approximately $38.1 million in net proceeds for the company.
  • In the process of transitioning OLED device deposition steps to European supply chain partners for U.S. DoD source of supply requirements, aiming to reduce reliance on Chinese supply and potential tariffs.

Negatives

  • History of losses and a significant accumulated deficit of $402.0 million as of December 28, 2024.
  • Negative cash flow from operating activities in fiscal years 2022, 2023, and 2024, with expectations for negative cash flow in fiscal year 2025.
  • Management has concluded there is substantial doubt about the company's ability to continue as a going concern within one year following the issuance of its annual report.
  • A post-trial order awarded BlueRadios, Inc. approximately $19.7 million in damages against the company, which is currently under appeal.
  • Identified material weaknesses in internal controls over financial reporting as of December 28, 2024.
  • Experienced quality issues with products supplied for the FWS-I program in 2023 and 2024, resulting in shipment suspensions and ongoing production process modifications.
  • Dependence on a Taiwanese foundry for AMLCD integrated circuits and a Chinese foundry for OLED deposition exposes the company to geopolitical risks and supply chain disruptions.
  • Most defense sales are on a fixed-price basis, which could subject the company to losses if there are cost overruns, especially with rising raw material and labor costs.
  • Generally does not have long-term contracts with customers, making revenue forecasting difficult and exposing the company to order cancellations.
  • Does not intend to pay dividends on common stock in the foreseeable future.

Risks

  • The Selling Stockholders may sell up to 19,545,950 shares of Common Stock, which could cause the stock price to decline and encourage short sales.
  • The company has a history of losses, a significant accumulated deficit ($402.0 million as of Dec 28, 2024), and negative cash flow from operating activities in fiscal years 2022, 2023, and 2024, with expectations for negative cash flow in 2025.
  • The company may need to raise additional capital to fund operations to continue as a going concern.
  • Raising additional funds by issuing securities may cause dilution to existing stockholders or restrict operations.
  • Material weaknesses in internal controls over financial reporting as of December 28, 2024, could lead to material misstatements or loss of investor confidence.
  • Revenues and cash flows could be negatively affected if sales of display products for defense applications significantly decline or current defense development programs are cancelled.
  • A decline in the U.S. Government defense budget, changes in spending priorities, government shutdowns, or delays in contract awards may adversely affect future revenues.
  • The company may be unable to manufacture products cost-effectively to meet contractual specifications or customer requirements, leading to potential losses from low production efficiency or product recalls.
  • Most defense sales are on a fixed-price basis, exposing the company to losses if there are cost overruns.
  • Investments in the development and sale of MicroLED and OLED microdisplays may not be successful, materially adversely affecting sales, profitability, and cash flow.
  • Business and financial performance may be adversely affected by cyber-attacks on information technology infrastructure and products, leading to fines, lawsuits, or loss of customers.
  • Supply shortages have and could continue to impair the quality, reduce the availability, or increase the cost of raw materials.
  • Geopolitical tensions and conflicts (e.g., Ukraine-Russia, China-Taiwan, Middle East) may negatively affect the ability to source materials and components.
  • The transition from a Chinese deposition foundry to a European foundry for certain OLED products for defense applications carries risks if the European products are not of the same quality or accepted by customers.
  • Business, results of operations, and financial condition could be adversely affected by events beyond the company's control, such as natural disasters, public health crises, or political crises.
  • The company generally does not have long-term contracts with customers, making revenue and operating results forecasting difficult.
  • U.S. Government contracts are generally not fully funded at inception and may be terminated or modified prior to completion, which could adversely affect the business.
  • Revenue recognition for some defense and commercial contracts on the over-time method requires significant management judgment, and errors could result in revenue adjustments.
  • The ability to manufacture and distribute display products would be severely limited if the foundries relied upon for integrated circuits fail to provide those services.
  • The company may be unable to adequately control purchase pricing of certain critical materials, which may materially adversely affect sales or profitability.
  • The markets in which the company operates are highly competitive and rapidly changing, and the company may be unable to compete successfully.
  • Disruptions of production (e.g., power outages, equipment failure) could adversely affect operating results.
  • A disruption to information technology systems could significantly impact operations, revenue, and profitability.
  • The company may not achieve some or all of the anticipated benefits of its equity investments.
  • If the company is unable to obtain or maintain existing software license relationships or other intellectual property relationships, its ability to grow revenue and achieve profitability may be negatively affected.
  • The business could suffer if the company fails to recruit and retain key personnel, including the President and CEO, Mr. Murray.
  • If the company fails to keep pace with changing technologies, it may lose customers.
  • The company may be unable to successfully integrate new strategic acquisitions and investments.
  • The company may incur substantial costs in defending its intellectual property and may not be successful in protecting its proprietary rights.
  • The process of seeking patent protection can be time-consuming and expensive, and there is no certainty that patents will be issued or provide adequate protection.
  • Changes in patent law could impair the company's ability to protect its tests and product candidates.
  • Patent terms may be inadequate to protect diagnostic tests or therapeutic product candidates.
  • Issued patents could be found invalid or unenforceable.
  • If the company does not obtain patent term extension, its business may be harmed.
  • The company enjoys only limited geographical protection with respect to certain patents.
  • If trademarks and trade names are not adequately protected, the company may not be able to build name recognition.
  • Changes in government trade policies may increase the cost of products, materially adversely affecting sales or profitability.
  • Failure to comply with complex procurement laws and regulations (e.g., FAR, TINA, CAS, ITAR) could lead to loss of business, fines, or debarment.
  • Customer demands and new regulations related to conflict-free minerals may adversely affect the company.
  • Changes in tax laws, an unfavorable resolution of tax examinations, or exposure to additional tax liabilities could have a material adverse effect on results of operations.
  • The company may incur significant liabilities if it fails to comply with stringent environmental laws and regulations and ITAR, or if it did not comply in the past.
  • The company may be unable to modify its products to meet regulatory or customer requirements.
  • Changes in China's laws, legal protections, or government policies on foreign investment in China may harm the business.
  • As a publicly traded company, the company is subject to significant regulation, including the Sarbanes-Oxley Act of 2002.
  • Fluctuations in operating results make financial forecasting difficult and could adversely affect the price of common stock.
  • The company does not intend to pay dividends on common stock in the foreseeable future, meaning returns depend solely on stock price appreciation.
  • Financial and operational projections are subject to inherent risks.
  • The company's stock price has fluctuated in the past, has recently been volatile, and may be volatile in the future.
  • Common Stock has often been thinly traded.
  • An investment in the company may involve tax implications.
  • The ability to use net operating loss carryforwards and certain other tax attributes may be limited.
  • The Board can designate classes of Preferred Stock without stockholder approval.
  • Provisions in corporate charter documents and under Delaware law could make an acquisition of the company more difficult.
  • Provisions in the Charter and Amended and Restated Bylaws could make a merger, tender offer, or proxy contest difficult.
  • Certain provisions of Delaware's General Corporation Law (DGCL) may have anti-takeover effects.
  • The Charter designates Delaware state or federal courts as the exclusive forum for disputes.
  • Provisions in the Charter and Amended and Restated Bylaws may discourage stockholders from bringing a lawsuit against directors and officers.
  • If analysts publish unfavorable research, or none at all, about the business, the stock price and trading volume could decline.
  • Any inability to report and file financial results accurately and timely could harm the business.

Future Outlook

The company expects to continue experiencing negative cash flow from operating activities in fiscal year 2025 and plans to invest in research and development even during periods of unprofitability. It anticipates customers switching to OLED microdisplays in the next two to three years and is investing substantially in MicroLED display development. Remediation efforts for identified material weaknesses in internal controls are ongoing and expected to continue in 2025. The U.S. Department of Defense is evaluating alternative display technologies for key programs, which may require the company to develop and qualify replacement technologies.

Management Comments

  • "We plan to continue to invest in research and development even during periods when we are not profitable, which may result in our incurring losses from operations and negative cash flow."
  • "We believe that for certain applications, OLED microdisplays have performance advantages and we have received future display product needs from some customers that plan to switch from AMCLDs to OLED microdisplays in the next two to three years."
  • "We are investing in the development of microLED display and the cost of such development we believe will be substantial."
  • "We are in the process of developing and implementing our remediation plan for the identified material weaknesses, and we expect that this work will continue in 2025."

Industry Context

Kopin Corporation operates in the highly competitive and rapidly evolving microdisplay and optical systems market, serving diverse sectors including defense, enterprise, industrial, consumer, and medical. The company's recent $15.4 million OTA award for MicroLED displays for ground soldier AR applications aligns with broader industry trends towards advanced augmented reality solutions in defense. The strategic investment from Theon International Plc, a global leader in thermal imaging and night vision, strengthens Kopin's position in international defense markets, particularly in Europe and NATO countries. However, the industry faces significant challenges, including global semiconductor shortages, geopolitical tensions impacting supply chains, and the need for continuous innovation to keep pace with emerging technologies like MicroLEDs, where Kopin competes with larger, better-resourced companies.

Comparison to Industry Standards

  • The filing does not provide specific comparisons to industry benchmarks or comparable companies/projects regarding financial performance or operational efficiency.
  • The company acknowledges competing against larger companies with greater financial, development, and marketing resources in the development of MicroLED displays, indicating a competitive disadvantage in this emerging technology area.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Regulatory Compliance StatusThe company operates as a smaller reporting company, utilizing scaled disclosures including exemption from SOX auditor attestation requirements and reduced executive compensation disclosure.N/AReduces compliance burden and costs for the company, but may provide less detailed financial and executive information to investors compared to larger public companies.
Anti-Takeover ProvisionsCorporate charter documents and Delaware law contain provisions that could make an acquisition of the company more difficult.N/AMay deter hostile takeovers, potentially allowing management to pursue long-term strategies but also limiting shareholders' ability to realize a premium from an acquisition.
Exclusive Forum ProvisionThe company's charter designates Delaware state or federal courts as the exclusive forum for certain legal disputes.N/ACentralizes litigation in a specific jurisdiction, potentially reducing legal costs and increasing predictability for the company, but may limit forum choice for shareholders.
Shareholder Litigation DeterrentsProvisions in the Charter and Amended and Restated Bylaws may discourage stockholders from initiating lawsuits against directors and officers.N/AAims to reduce litigation risk for management, but could be perceived as limiting shareholder recourse for fiduciary duty breaches.
Internal Control WeaknessesManagement identified material weaknesses in internal controls over financial reporting as of December 28, 2024.December 28, 2024Increases the risk of material misstatements in financial statements and could lead to a loss of investor confidence; remediation efforts are ongoing.

Legal Proceedings

  • On September 5, 2025, a post-trial order was entered in the U.S. District Court for the District of Colorado in the matter of BlueRadios, Inc. v. Kopin Corporation, Inc., finding for the plaintiff and awarding approximately $19.7 million in damages, while denying a permanent injunction and prejudgment interest.
  • The company had previously accrued $24.8 million as possible damages for this litigation in the second quarter of 2024.
  • On October 7, 2025, Kopin Corporation filed an appeal of the $19.7 million judgment and posted a $23.0 million bond (consisting of the judgment, legal expenses, and interest) through loan agreements with its bank and a Letter of Credit to a surety company.

Related Party Transactions

  • Theon International Plc, which made a $15.0 million strategic investment, now holds a 49% equity interest in Kopin Europe Limited and has purchased Series A Convertible Preferred Stock of Kopin Corporation, establishing a related party relationship.

Stakeholder Impact

  • Shareholders: Face potential dilution from future equity raises, risk of stock price decline due to the resale of 19.5 million shares by selling stockholders, no dividends expected in the foreseeable future, and a high degree of investment risk due to the company's financial condition and operational challenges.
  • Employees: Retention of key personnel is critical for the company's success, and an inducement award was granted to a key officer.
  • Customers: Quality issues with products supplied for the FWS-I program could impact customer confidence, but the company is a critical supplier for defense applications and is developing new products (OLED, MicroLED) to meet future needs.
  • Suppliers: The company's reliance on specific foundries and raw material suppliers exposes it to supply chain disruptions and geopolitical risks; the transition to a European foundry for OLEDs may impact existing supplier relationships.
  • Creditors: The company's 'going concern' warning and history of losses pose significant risks; loan agreements were entered into to secure the appeal bond for the BlueRadios judgment.

Next Steps

  • Continue to invest in research and development, particularly for MicroLED displays, even during periods of unprofitability.
  • Remediate identified material weaknesses in internal controls over financial reporting, with work expected to continue in 2025.
  • Develop and qualify replacement display technologies as the U.S. Department of Defense evaluates alternatives for the F-35 Strike Fighter program and other defense programs.
  • Execute the transition from a Chinese deposition foundry to a European foundry for certain OLED products for defense applications.
  • Proceed with the appeal of the $19.7 million judgment in the BlueRadios, Inc. v. Kopin Corporation, Inc. case.
  • Selling stockholders may sell up to 19,545,950 shares of common stock from time to time in the public market.

Key Dates

DateDescription
April 23, 1984Kopin Corporation incorporated in the State of Delaware.
April 12, 2019Sixth Amended and Restated By-laws filed.
May 20, 2020Kopin Corporation 2020 Equity Incentive Plan filed.
December 31, 2020Tenth Amended and Restated Employment Agreement between the Company and Dr. John C.C. Fan.
December 25, 2021Fiscal year ended.
July 14, 2022Letter Agreement between Kopin Corporation and Michael Murray.
September 5, 2022Amendment to Employment Agreement between Kopin Corporation and John C. C. Fan.
September 24, 2022Quarterly period ended.
Fiscal Year 2022Negative cash flow from operating activities.
December 30, 2023Fiscal year ended.
Fiscal Year 2023Negative cash flow from operating activities; experienced quality issues with FWS-I products.
March 14, 2024RSM US LLP report date for consolidated financial statements as of December 30, 2023.
March 30, 2024Quarterly period ended.
April 5, 2024Employment Agreement between Kopin Corporation and Michael Murray.
June 6, 2024Form of Indemnification Agreement filed.
June 11, 2024Amended and Restated Certificate of Incorporation filed.
Second Quarter 2024Company accrued $24.8 million as possible damages for a litigation issue.
September 20, 2024Underwriting Agreement filed.
December 28, 2024Fiscal year ended; accumulated deficit of $402.0 million; cash and cash equivalents $36.6 million; net cash used in operating activities $14.2 million; management identified material weaknesses in internal controls.
Fiscal Year 2024Negative cash flow from operating activities; experienced quality issues with FWS-I products; recorded an impairment charge of $0.7 million on an equity investment.
January 8, 2025Current Report on Form 8-K filed.
January 24, 2025Current Report on Form 8-K filed.
March 29, 2025Quarterly period ended.
April 17, 2025Annual Report on Form 10-K for the year ended December 28, 2024, filed.
May 13, 2025Form 10-K/A filed; Quarterly Report on Form 10-Q for the period ended March 29, 2025, filed.
May 20, 2025Amendment No. 2 to Form 10-K/A filed; Proxy Statement on Schedule 14A filed.
May 29, 2025Current Report on Form 8-K filed.
June 10, 2025Placement Agency Agreement with Stifel, Nicolaus & Company, Incorporated, LLC.
June 28, 2025Quarterly period ended.
June 30, 2025Current Report on Form 8-K filed.
August 7, 2025Current Report on Form 8-K filed.
August 8, 2025Series A Convertible Preferred Stock Purchase Agreement with Theon International PLC.
August 11, 2025Announced a $15.0 million strategic investment by Theon International Plc.
August 12, 2025Current Report on Form 8-K filed; Quarterly Report on Form 10-Q for the period ended June 28, 2025, filed.
August 14, 2025Announced an approximate $9 million follow-on production contract; Current Report on Form 8-K filed.
September 4, 2025Entered into an Inducement Restricted Stock Award Agreement with Erich Manz.
September 5, 2025Post-trial order entered in the U.S. District Court for the District of Colorado in the matter of BlueRadios, Inc. v. Kopin Corporation, Inc. finding for the plaintiff and awarding approximately $19.7 million in damages; Current Report on Form 8-K filed.
September 15, 2025Announced award of a $15.4 million Other Transaction Agreement (OTA) from the Office of the Secretary of Defense (OSD).
September 23, 2025Placement Agency Agreement amended.
September 27, 2025Capitalization date for actual figures; Quarterly period ended.
September 29, 2025Entered into a securities purchase agreement for a private investment in public equity financing (PIPE) for 19,545,950 shares of common stock; entered into a registration rights agreement.
September 30, 2025PIPE transaction closed; First Amendment to Series A Convertible Preferred Stock Purchase Agreement with Theon International PLC; Current Report on Form 8-K filed.
October 3, 2025Current Report on Form 8-K filed.
October 7, 2025Filed an appeal of the $19.7 million judgment against the company in Blue Radios Inc. v. Kopin Corporation; entered into loan agreements for a $23.0 million bond.
October 10, 2025Current Report on Form 8-K filed.
October 16, 2025Theon International Plc transaction closed, including an $8.0 million investment into Kopin Europe Limited and a $7.0 million purchase of Series A Convertible Preferred Stock; Shareholders Agreement and License and Collaboration Agreement dated; Current Report on Form 8-K filed.
November 7, 2025Form S-1 filed (referencing agreements).
November 9, 2025Deadline for filing a registration statement providing for the resale of the Placement Shares.
November 12, 2025Quarterly Report on Form 10-Q for the period ended September 27, 2025, filed.
November 21, 2025Date for common stock outstanding calculation (182,540,805 shares).
November 24, 2025Last reported sale price of common stock on The Nasdaq Capital Market was $2.33 per share.
November 25, 2025Filing date of Amendment No. 1 to Form S-1; BDO USA, P.C. and RSM US LLP consent dates; signed by Michael Murray, Jill Avery, David Nieuwsma, Margaret Seif, Paul Walsh Jr., and Erich Manz.
Fiscal Year 2025Expected negative cash flow from operating activities; remediation plan for material weaknesses expected to continue.
December 10, 2026First vesting date for Erich Manz's restricted shares.

Recommendation

sell

The filing reveals a highly concerning financial situation, including a history of significant losses, persistent negative cash flow from operations, and an explicit 'substantial doubt about our ability to continue as a going concern.' The identification of material weaknesses in internal controls over financial reporting further undermines confidence in financial integrity. While recent strategic investments and defense contracts offer some potential, these are overshadowed by the fundamental financial instability, the significant legal judgment against the company, and the impending resale of a large block of shares by existing stockholders, which will likely create downward pressure on the stock price. For a seasoned investor, these factors collectively indicate a high-risk investment with significant downside potential and warrant a 'sell' recommendation.

Keywords

Kopin Corporation, KOPN, SEC filing, S-1/A, common stock resale, private placement, PIPE financing, microdisplays, OLED, MicroLED, defense technology, augmented reality, thermal imaging, U.S. Department of Defense, Theon International, strategic investment, corporate governance, risk factors, financial reporting, internal controls, supply chain, intellectual property, government contracts, capital raise

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.